Story perspectives

Employers Tighten GLP-1 Coverage Amid Rising Demand

10/24/2025

34 4

Summary

Story summary

Employers are restricting coverage for GLP-1 weight loss drugs as demand rises and costs exceed expectations.
The anticipated introduction of oral GLP-1 therapies is expected to broaden treatment options.
However, these oral options may not significantly lower prices.
Rising premiums and deductibles strain employer budgets as they balance access and affordability.
New indications for GLP-1s are emerging, but overlapping patient populations may limit increased utilization.

1 of 1

Story summary

Employers are restricting coverage for GLP-1 weight loss drugs as demand rises and costs exceed expectations.
The anticipated introduction of oral GLP-1 therapies is expected to broaden treatment options.
However, these oral options may not significantly lower prices.
Rising premiums and deductibles strain employer budgets as they balance access and affordability.
New indications for GLP-1s are emerging, but overlapping patient populations may limit increased utilization.